Skip to Content

Acupuncture Effective for Chronic Muscular Pain in Cancer Survivors

TUESDAY, April 6, 2021 -- Electroacupuncture and auricular acupuncture are more effective than usual care at reducing chronic musculoskeletal pain in cancer survivors, according to a study published online March 18 in JAMA Oncology.

Jun J. Mao, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues assessed the effectiveness of electroacupuncture (145 patients) or auricular acupuncture (143 patients) versus usual care (72 patients) for chronic musculoskeletal pain in cancer survivors. Improvement in musculoskeletal pain was assessed at week 12.

The researchers found that electroacupuncture reduced pain severity by 1.9 points and auricular acupuncture reduced severity by 1.6 points from baseline to week 12 compared with usual care. Auricular acupuncture was not noninferior to electroacupuncture. Adverse events were mild, with 10.5 percent of patients receiving auricular acupuncture and 0.7 percent of patients receiving electroacupuncture discontinuing treatments due to adverse events.

"In this randomized clinical trial of diverse cancer survivors with chronic musculoskeletal pain, electroacupuncture and auricular acupuncture improved pain severity, pain-related functional interference, and quality of life, and reduced analgesic use compared with usual care," the authors write.

Two authors disclosed financial ties to the biopharmaceutical industry; one author disclosed ties to the Tibet Cheezheng Tibetan Medicine Co.

Abstract/Full Text

© 2021 HealthDay. All rights reserved.

Read this next

Cutaneous AEs Linked to Immune Checkpoint Inhibitor Therapy

TUESDAY, April 20, 2021 -- Cutaneous immune-related adverse events (irAEs) are associated with initiation of immune checkpoint inhibitor (ICI) treatment in cancer patients,...

Routine Cancer Screenings Declined Significantly at Start of Pandemic

THURSDAY, April 15, 2021 -- Following the COVID-19 national emergency declaration March 13, 2020, mammography and colonoscopy rates declined by more than 90 percent among...

AACR: Personalized Vaccine for Cancer Tolerated, Feasible

MONDAY, April 12, 2021 -- A personalized vaccine can be synthesized and is feasible for administration to patients with cancer, according to a study presented during Week 1 of the...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.